4/A
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-047582
Chief Financial Officer bought 8,000 shares at an average $8.73 ($69,860)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Plavan Matthew T Chief Financial Officer | 2019-08-26 | Purchase | +1,000 | $8.33 | $8,330 | 1,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-26 | Purchase | +1,000 | $9.22 | $9,220 | 2,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Purchase | +1,000 | $9.32 | $9,320 | 3,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Purchase | +1,000 | $9.30 | $9,300 | 4,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Purchase | +1,000 | $8.95 | $8,950 | 5,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-27 | Purchase | +2,000 | $8.93 | $17,860 | 7,000 | D |
| Plavan Matthew T Chief Financial Officer | 2019-08-28 | Purchase | +1,000 | $6.88 | $6,880 | 8,000 | D |
| Open-market purchases · 8,000 sh · avg $8.73 · $69,860 | |||||||
Loading xslF345X03/doc4a.xml…